Macter International Limited has proposed subdividing its shares by reducing their face value from Rs. 10 to Rs. 2 per share, a move aimed at improving market liquidity and making the stock more accessible to investors.
The proposal was considered by the company’s Board of Directors at a meeting on September 22 and will be presented to shareholders for approval at the upcoming Annual General Meeting, subject to regulatory approvals.
Under the proposed subdivision, each existing ordinary share of Rs. 10 will be converted into five ordinary shares of Rs. 2 each. The company’s total issued, subscribed and paid-up capital will remain unchanged.
Macter’s share count will increase from 45,811,018 ordinary shares of Rs. 10 each to 229,055,090 ordinary shares of Rs. 2 each.
Shareholders holding one ordinary share of Rs. 10 on the effective date will receive five ordinary shares of Rs. 2 each under the proposed arrangement.
The company said the subdivision is intended to enhance market liquidity, improve investor accessibility and align Macter’s stock price with broader market participation. Macter International Limited is a Pakistani pharmaceutical company incorporated in 1992 with its shares listed on the Pakistan Stock Exchange since 2017.
The company manufactures and markets pharmaceutical products across a wide range of dosage forms, including tablets, capsules, syrups, injectables, creams and inhalers, and is also a major contract manufacturer for international healthcare companies.
The post Macter International Proposes 5-for-1 Share Split appeared first on ProPakistani.